Peripartum cardiomyopathy

Circulation

Volumn 133, Issue 14, 2016, Pages 1397-1409

  Arany, Zolt ^a   Elkayam, Uri ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

cardiomyopathies; heart failure; pre eclampsia; pregnancy

Indexed keywords

ANTIARRHYTHMIC AGENT; BROMOCRIPTINE; PROLACTIN; PROTEIN TYROSINE KINASE; SOLUBLE FMS LIKE TYROSINE KINASE 1; UNCLASSIFIED DRUG; CARDIOVASCULAR AGENT; HORMONE;

ANTICOAGULATION; ARTICLE; BREAST FEEDING; HEART ARRHYTHMIA; HEART ASSIST DEVICE; HEMODYNAMICS; HUMAN; HYPERTENSION; MORTALITY; NONHUMAN; OBSTETRICS; PATHOPHYSIOLOGY; PERIPARTUM CARDIOMYOPATHY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; RACE; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; THROMBOEMBOLISM; TRANSPLANTATION; BLOOD; CARDIOMYOPATHIES; COMPLICATION; DISEASE PREDISPOSITION; DRUG EFFECTS; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; INCIDENCE; LACTATION; MULTIPLE PREGNANCY; NEWBORN; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PUERPERAL DISORDERS;

BROMOCRIPTINE; CARDIOMYOPATHIES; CARDIOVASCULAR AGENTS; DISEASE SUSCEPTIBILITY; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HORMONES; HUMANS; HYPERTENSION; INCIDENCE; INFANT, NEWBORN; LACTATION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY, MULTIPLE; PUERPERAL DISORDERS;

EID: 84964335917     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.020491     Document Type: Article

References (125)

1. Porak C, De L'influence reciproque de la grossesse et del maladies du Coeur [thesis] 1880 France Medical Faculty of Paris
2. Ritchie C, Clinical contribution to the pathology, diagnosis, and treatment of certain chronic diseases of the heart. Edinburgh Med Surg J 1849 185 333 342
3. Hull E, Hafkesbring E, Toxic postpartal heart disease. N Orleans Med Surg J 1937 89 550
4. Hull E, Hidden E, Postpartal heart failure. Southern Med J 1938 31 265
5. Demakis JG, Rahimtoola SH, Peripartum cardiomyopathy. Circulation 1971 44 964 968
6. Demakis JG, Rahimtoola SH, Sutton GC, Meadows WR, Szanto PB, Tobin JR, Gunnar RM, Natural course of peripartum cardiomyopathy. Circulation 1971 44 1053 1061
7. Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, Ansari A, Baughman KL, Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000 283 1183 1188
8. Hibbard JU, Lindheimer M, Lang RM, A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol 1999 94 311 316
9. Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, Regitz-Zagrosek V, Schaufelberger M, Tavazzi L, van Veldhuisen DJ, Watkins H, Shah AJ, Seferovic PM, Elkayam U, Pankuweit S, Papp Z, Mouquet F, McMurray JJ, Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Eur J Heart Fail 2010 12 767 778. doi: 10.1093/eurjhf/hfq120.
10. Citro R, Giudice R, Mirra M, Petta R, Baldi C, Bossone E, Piscione F, Is Tako-tsubo syndrome in the postpartum period a clinical entity different from peripartum cardiomyopathy? J Cardiovasc Med (Hagerstown) 2013 14 568 575. doi: 10.2459/JCM.0b013e32835f1a49.
11. Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, Shotan A, Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005 111 2050 2055. doi: 10.1161/01.CIR.0000162478.36652.7E.
12. Pillarisetti J, Kondur A, Alani A, Reddy M, Reddy M, Vacek J, Weiner CP, Ellerbeck E, Schreiber T, Lakkireddy D, Peripartum cardiomyopathy: predictors of recovery and current state of implantable cardioverter-defibrillator use. J Am Coll Cardiol 2014 63 pt A 2831 2839. doi: 10.1016/j.jacc.2014.04.014.
13. Liu LX, Arany Z, Maternal cardiac metabolism in pregnancy. Cardiovasc Res 2014 101 545 553. doi: 10.1093/cvr/cvu009.
14. Ntusi NB, Mayosi BM, Aetiology and risk factors of peripartum cardiomyopathy: a systematic review. Int J Cardiol 2009 131 168 179. doi: 10.1016/j.ijcard.2008.06.054.
15. Mielniczuk LM, Williams K, Davis DR, Tang AS, Lemery R, Green MS, Gollob MH, Haddad H, Birnie DH, Frequency of peripartum cardiomyopathy. Am J Cardiol 2006 97 1765 1768. doi: 10.1016/j.amjcard.2006.01.039.
16. Brar SS, Khan SS, Sandhu GK, Jorgensen MB, Parikh N, Hsu JW, Shen AY, Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol 2007 100 302 304. doi: 10.1016/j.amjcard.2007.02.092.
17. Gunderson EP, Croen LA, Chiang V, Yoshida CK, Walton D, Go AS, Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes. Obstet Gynecol 2011 118 583 591. doi: 10.1097/AOG.0b013e318229e6de.
18. Kolte D, Khera S, Aronow WS, Palaniswamy C, Mujib M, Ahn C, Jain D, Gass A, Ahmed A, Panza JA, Fonarow GC, Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc 2014 3 e001056. doi: 10.1161/JAHA.114.001056.
19. Main EK, McCain CL, Morton CH, Holtby S, Lawton ES, Pregnancy-related mortality in California: causes, characteristics, and improvement opportunities. Obstet Gynecol 2015 125 938 947. doi: 10.1097/AOG.0000000000000746.
20. Desai D, Moodley J, Naidoo D, Peripartum cardiomyopathy: experiences at King Edward VIII Hospital, Durban, South Africa and a review of the literature. Trop Doct 1995 25 118 123
21. Sliwa K, Damasceno A, Mayosi BM, Epidemiology and etiology of cardiomyopathy in Africa. Circulation 2005 112 3577 3583. doi: 10.1161/CIRCULATIONAHA.105.542894.
22. Hasan JA, Qureshi A, Ramejo BB, Kamran A, Peripartum cardiomyopathy characteristics and outcome in a tertiary care hospital. J Pak Med Assoc 2010 60 377 380
23. Pandit V, Shetty S, Kumar A, Sagir A, Incidence and outcome of peripartum cardiomyopathy from a tertiary hospital in South India. Trop Doct 2009 39 168 169. doi: 10.1258/td.2008.080353.
24. Fett JD, Christie LG, Carraway RD, Murphy JG, Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc 2005 80 1602 1606. doi: 10.4065/80.12.1602.
25. Isezuo SA, Abubakar SA, Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital. Ethn Dis 2007 17 228 233
26. Karaye KM, Yahaya IA, Lindmark K, Henein MY, Serum selenium and ceruloplasmin in Nigerians with peripartum cardiomyopathy. Int J Mol Sci 2015 16 7644 7654. doi: 10.3390/ijms16047644.
27. Witlin AG, Mabie WC, Sibai BM, Peripartum cardiomyopathy: an ominous diagnosis. Am J Obstet Gynecol 1997 176 pt 1 182 188
28. Gentry MB, Dias JK, Luis A, Patel R, Thornton J, Reed GL, African-American women have a higher risk for developing peripartum cardiomyopathy. J Am Coll Cardiol 2010 55 654 659. doi: 10.1016/j.jacc.2009.09.043.
29. Goland S, Modi K, Hatamizadeh P, Elkayam U, Differences in clinical profile of African-American women with peripartum cardiomyopathy in the United States. J Card Fail 2013 19 214 218. doi: 10.1016/j.cardfail.2013.03.004.
30. Harper MA, Meyer RE, Berg CJ, Peripartum cardiomyopathy: population-based birth prevalence and 7-year mortality. Obstet Gynecol 2012 120 1013 1019. doi: http://10.1097/AOG.0b013e31826e46a1.
31. Bello N, Rendon IS, Arany Z, The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J Am Coll Cardiol 2013 62 1715 1723. doi: 10.1016/j.jacc.2013.08.717.
32. Kao DP, Hsich E, Lindenfeld J, Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy. JACC Heart Fail 2013 1 409 416. doi: 10.1016/j.jchf.2013.04.011.
33. Fong A, Chau CT, Pan D, Ogunyemi DA, Clinical morbidities, trends, and demographics of eclampsia: a population-based study. Am J Obstet Gynecol 2013 209 229.e1 229.e7. doi: 10.1016/j.ajog.2013.05.050.
34. Ntusi NB, Badri M, Gumedze F, Sliwa K, Mayosi BM, Pregnancy-associated heart failure: a comparison of clinical presentation and outcome between hypertensive heart failure of pregnancy and idiopathic peripartum cardiomyopathy. PLoS One 2015 10 e0133466. doi: 10.1371/journal.pone.0133466.
35. Melchiorre K, Sutherland GR, Baltabaeva A, Liberati M, Thilaganathan B, Maternal cardiac dysfunction and remodeling in women with preeclampsia at term. Hypertension 2011 57 85 93. doi: 10.1161/HYPERTENSIONAHA.110.162321.
36. Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B, Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension 2011 58 709 715. doi: 10.1161/HYPERTENSIONAHA.111.176537.
37. Shahul S, Rhee J, Hacker MR, Gulati G, Mitchell JD, Hess P, Mahmood F, Arany Z, Rana S, Talmor D, Subclinical left ventricular dysfunction in preeclamptic women with preserved left ventricular ejection fraction: a 2D speckle-tracking imaging study. Circ Cardiovasc Imaging 2012 5 734 739. doi: 10.1161/CIRCIMAGING.112.973818.
38. Russell RB, Petrini JR, Damus K, Mattison DR, Schwarz RH, The changing epidemiology of multiple births in the United States. Obstet Gynecol 2003 101 129 135
39. Altun I Akin F, Biteker M, Peripartum cardiomyopathy and triplet pregnancy. Anatol J Cardiol 2015 15 85 86. doi: 10.5152/akd.2014.5693.
40. Günaydin ZY, Gürel YE, Erdoǧan G, Kaya A, Peripartum cardiomyopathy associated with triplet pregnancy. Anadolu Kardiyol Derg 2014 14 661 662. doi: 10.5152/akd.2014.5668.
41. Chapa JB, Heiberger HB, Weinert L, Decara J, Lang RM, Hibbard JU, Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol 2005 105 1303 1308. doi: 10.1097/01.AOG.0000161382.30233.ba.
42. Elkayam U, Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol 2011 58 659 670. doi: 10.1016/j.jacc.2011.03.047.
43. Arany ZP, Walker CM, Wang L, Case records of the Massachusetts General Hospital: case 22-2014: a 40-year-old woman with postpartum dyspnea and hypoxemia. N Engl J Med 2014 371 261 269. doi: 10.1056/NEJMcpc1304163.
44. Halkein J, Tabruyn SP, Ricke-Hoch M, Haghikia A, Nguyen NQ, Scherr M, Castermans K, Malvaux L, Lambert V, Thiry M, Sliwa K, Noel A, Martial JA, Hilfiker-Kleiner D, Struman I, MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest 2013 123 2143 2154. doi: 10.1172/JCI64365.
45. Sliwa K, Skudicky D, Candy G, Bergemann A, Hopley M, Sareli P, The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur J Heart Fail 2002 4 305 309
46. Desplantie O, Tremblay-Gravel M, Avram R, Marquis-Gravel G, Ducharme A, Jolicoeur EM, BRO-HF Initiative Investigators The medical treatment of new-onset peripartum cardiomyopathy: a systematic review of prospective studies. Can J Cardiol 2015 31 1421 1426. doi: 10.1016/j.cjca.2015.04.029.
47. Sliwa K, Blauwet L, Tibazarwa K, Libhaber E, Smedema JP, Becker A, McMurray J, Yamac H, Labidi S, Struman I, Struhman I, Hilfiker-Kleiner D, Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 2010 121 1465 1473. doi: 10.1161/CIRCULATIONAHA.109.901496.
48. Cleland JG, Cullington D, Digoxin: quo vadis? Circ Heart Fail 2009 2 81 85. doi: 10.1161/CIRCHEARTFAILURE.109.859322.
49. Chaggar PS, Shaw SM, Williams SG, Is foxglove effective in heart failure? Cardiovasc Ther 2015 33 236 241. doi: 10.1111/1755-5922.12130.
50. Bozkurt B, Villaneuva FS, Holubkov R, Tokarczyk T, Alvarez RJ Jr, MacGowan GA, Murali S, Rosenblum WD, Feldman AM, McNamara DM, Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol 1999 34 177 180
51. McNamara DM, Holubkov R, Starling RC, Dec GW, Loh E, Torre-Amione G, Gass A, Janosko K, Tokarczyk T, Kessler P, Mann DL, Feldman AM, Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 2001 103 2254 2259
52. Biteker M, Duran NE, Kaya H, Gündüz S, Tanboǧa HÎ Gökdeniz T, Kahveci G, Akgün T, Yildiz M, Õzkan M, Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial. Clin Res Cardiol 2011 100 571 577. doi: 10.1007/s00392-010-0279-7.
53. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O, Quint A, Landmesser U, Doerries C, Luchtefeld M, Poli V, Schneider MD, Balligand JL, Desjardins F, Ansari A, Struman I, Nguyen NQ, Zschemisch NH, Klein G, Heusch G, Schulz R, Hilfiker A, Drexler H, A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007 128 589 600. doi: 10.1016/j.cell.2006.12.036.
54. Gaziano JM, Cincotta AH, O'Connor CM, Ezrokhi M, Rutty D, Ma ZJ, Scranton RE, Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes. Diabetes Care 2010 33 1503 1508. doi: 10.2337/dc09-2009.
55. Francis GS, Parks R, Cohn JN, The effects of bromocriptine in patients with congestive heart failure. Am Heart J 1983 106 pt 1 100 106
56. Haghikia A, Podewski E, Libhaber E, Labidi S, Fischer D, Roentgen P, Tsikas D, Jordan J, Lichtinghagen R, von Kaisenberg CS, Struman I, Bovy N, Sliwa K, Bauersachs J, Hilfiker-Kleiner D, Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol 2013 108 366. doi: 10.1007/s00395-013-0366-9.
57. Turkalj I, Braun P, Krupp P, Surveillance of bromocriptine in pregnancy. JAMA 1982 247 1589 1591
58. US Food and Drug Administration Sandoz Pharmaceutical Corp.; bromocriptine mesylate (Parlodel); withdrawal of approval of the indication for the prevention of physiological lactation. Fed Reg 1995 60 3404 3405
59. Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, Ezzati M, Grantham-McGregor S, Katz J, Martorell R, Uauy R, Maternal and Child Nutrition Study Group Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013 382 427 451. doi: 10.1016/S0140-6736(13)60937-X.
60. Safirstein JG, Ro AS, Grandhi S, Wang L, Fett JD, Staniloae C, Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet. Int J Cardiol 2012 154 27 31. doi: 10.1016/j.ijcard.2010.08.065.
61. Haghikia A, Podewski E, Berliner D, Sonnenschein K, Fischer D, Angermann CE, Böhm M, Röntgen P, Bauersachs J, Hilfiker-Kleiner D, Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy. Clin Res Cardiol 2015 104 911 917. doi: 10.1007/s00392-015-0869-5.
62. Greer IA, Clinical practice: pregnancy complicated by venous thrombosis. N Engl J Med 2015 373 540 547. doi: 10.1056/NEJMcp1407434.
63. Altuwaijri WA, Kirkpatrick ID, Jassal DS, Soni A, Vanishing left ventricular thrombus in a woman with peripartum cardiomyopathy: a case report. BMC Res Notes 2012 5 544. doi: 10.1186/1756-0500-5-544.
64. Shimamoto T, Marui A, Oda M, Tomita S, Nakajima H, Takeuchi T, Komeda M, A case of peripartum cardiomyopathy with recurrent left ventricular apical thrombus. Circ J 2008 72 853 854
65. Kharwar RB, Chandra S, Dwivedi SK, Saran RK, A pedunculated left ventricular thrombus in a women with peripartum cardiomyopathy: evaluation by three dimensional echocardiography. J Cardiovasc Ultrasound 2014 22 139 143. doi: 10.4250/jcu.2014.22.3.139.
66. Kim DY, Islam S, Mondal NT, Mussell F, Rauchholz M, Biventricular thrombi associated with peripartum cardiomyopathy. J Health Popul Nutr 2011 29 178 180
67. Goland S, Modi K, Bitar F, Janmohamed M, Mirocha JM, Czer LS, Illum S, Hatamizadeh P, Elkayam U, Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail 2009 15 645 650. doi: 10.1016/j.cardfail.2009.03.008.
68. Zehir R, Karabay CY, Kocabay G, Kalayci A, Akgun T, Kirma C, An unusual presentation of peripartum cardiomyopathy: recurrent transient ischemic attacks. Rev Port Cardiol 2014 33 561.e1 561.e3. doi: 10.1016/j.repc.2014.02.025.
69. Kane A, Mbaye M, Ndiaye MB, Diao M, Moreira PM, Mboup C, Diop IB, Sarr M, Kane A, Moreau JC, Ba SA, Evolution and thromboembolic complications of the idiopathic peripartal cardiomyopathy at Dakar University Hospital: forward-looking study about 33 cases [in French]. J Gynecol Obstet Biol Reprod (Paris) 2010 39 484 489. doi: 10.1016/j.jgyn.2010.01.008.
70. Diao M, Diop IB, Kane A, Camara S, Kane A, Sarr M, Ba SA, Diouf SM, Electrocardiographic recording of long duration (Holter) of 24 hours during idiopathic cardiomyopathy of the peripartum [in French]. Arch Mal Coeur Vaiss 2004 97 25 30
71. Tokuda M, Stevenson WG, Nagashima K, Rubin DA, Electrophysiological mapping and radiofrequency catheter ablation for ventricular tachycardia in a patient with peripartum cardiomyopathy. J Cardiovasc Electrophysiol 2013 24 1299 1301. doi: 10.1111/jce.12250.
72. DeBenedetti Zunino ME, Schuger C, Lahiri M, High rate of ventricular arrhythmias in women with peripartum cardiomyopathy and implanted cardioverter defibrillators. J Am Coll Cardiol 2014 63. doi: 10.1016/S0735-1097(14)60313-2.
73. Duncker D, Haghikia A, König T, Hohmann S, Gutleben KJ, Westenfeld R, Oswald H, Klein H, Bauersachs J, Hilfiker-Kleiner D, Veltmann C, Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function: value of the wearable cardioverter/defibrillator. Eur J Heart Fail 2014 16 1331 1336. doi: 10.1002/ejhf.188.
74. Saltzberg MT, Szymkiewicz S, Bianco NR, Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator. J Card Fail 2012 18 21 27. doi: 10.1016/j.cardfail.2011.09.004.
75. Su TW, Tseng YH, Wu TI, Lin PJ, Wu MY, Extracorporeal life support in adults with hemodynamic collapse from fulminant cardiomyopathies: the chance of bridging to recovery. ASAIO J 2014 60 664 669. doi: 10.1097/MAT.0000000000000141.
76. Park SH, Chin JY, Choi MS, Choi JH, Choi YJ, Jung KT, Extracorporeal membrane oxygenation saved a mother and her son from fulminant peripartum cardiomyopathy. J Obstet Gynaecol Res 2014 40 1940 1943. doi: 10.1111/jog.12421.
77. Bouabdallaoui N, Mastroianni C, Revelli L, Demondion P, Lebreton G, Predelivery extracorporeal membrane oxygenation in a life-threatening peripartum cardiomyopathy: save both mother and child. Am J Emerg Med 2015 33 1713.e1 1713.e2. doi: 10.1016/j.ajem.2015.03.014.
78. Gevaert S, Van Belleghem Y, Bouchez S, Herck I, De Somer F, De Block Y, Tromp F, Vandecasteele E, Martens F, De Pauw M, Acute and critically ill peripartum cardiomyopathy and "bridge to" therapeutic options: a single center experience with intra-aortic balloon pump, extra corporeal membrane oxygenation and continuous-flow left ventricular assist devices. Crit Care 2011 15 R93. doi: 10.1186/cc10098.
79. Aggarwal A, Modi S, Kumar S, Korrapati C, Tatooles A, Pappas PS, Bhat G, Use of a single-circuit CentriMag® for biventricular support in postpartum cardiomyopathy. Perfusion 2013 28 156 159. doi: 10.1177/0267659112464713.
80. McNamara DM, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G, Modi K, Alexis JD, Ramani GV, Semigran MJ, Haythe J, Markham DW, Marek J, Gorcsan J 3rd, Wu WC, Lin Y, Halder I, Pisarcik J, Cooper LT, Fett JD, IPAC Investigators Clinical outcomes for peripartum cardiomyopathy in north america: results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol 2015 66 905 914. doi: 10.1016/j.jacc.2015.06.1309.
81. Amos AM, Jaber WA, Russell SD, Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J 2006 152 509 513. doi: 10.1016/j.ahj.2006.02.008.
82. Loyaga-Rendon RY, Pamboukian SV, Tallaj JA, Acharya D, Cantor R, Starling RC, Naftel D, Kirklin J, Outcomes of patients with peripartum cardiomyopathy who received mechanical circulatory support: data from the Interagency Registry for Mechanically Assisted Circulatory Support. Circ Heart Fail 2014 7 300 309. doi: 10.1161/CIRCHEARTFAILURE.113.000721.
83. Rasmusson K, Brunisholz K, Budge D, Horne BD, Alharethi R, Folsom J, Connolly JJ, Stehlik J, Kfoury A, Peripartum cardiomyopathy: post-transplant outcomes from the United Network for Organ Sharing Database. J Heart Lung Transplant 2012 31 180 186. doi: 10.1016/j.healun.2011.11.018.
84. Laghari AH, Khan AH, Kazmi KA, Peripartum cardiomyopathy: ten year experience at a tertiary care hospital in Pakistan. BMC Res Notes 2013 6 495. doi: 10.1186/1756-0500-6-495.
85. Kamiya CA, Kitakaze M, Ishibashi-Ueda H, Nakatani S, Murohara T, Tomoike H, Ikeda T, Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders: results from the Japanese nationwide survey of peripartum cardiomyopathy. Circ J 2011 75 1975 1981
86. Sliwa K, Libhaber E, Elliott C, Momberg Z, Osman A, Zühlke L, Lachmann T, Nicholson L, Thienemann F, Roos-Hesselink J, Anthony J, Spectrum of cardiac disease in maternity in a low-resource cohort in South Africa. Heart 2014 100 1967 1974. doi: 10.1136/heartjnl-2014-306199.
87. Blauwet LA, Libhaber E, Forster O, Tibazarwa K, Mebazaa A, Hilfiker-Kleiner D, Sliwa K, Predictors of outcome in 176 South African patients with peripartum cardiomyopathy. Heart 2013 99 308 313. doi: 10.1136/heartjnl-2012-302760.
88. Biteker M, Ilhan E, Biteker G, Duman D, Bozkurt B, Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow-up and sustained therapy. Eur J Heart Fail 2012 14 895 901. doi: 10.1093/eurjhf/hfs070.
89. Goland S, Bitar F, Modi K, Safirstein J, Ro A, Mirocha J, Khatri N, Elkayam U, Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy. J Card Fail 2011 17 426 430. doi: 10.1016/j.cardfail.2011.01.007.
90. Hu CL, Li YB, Zou YG, Zhang JM, Chen JB, Liu J, Tang YH, Tang QZ, Huang CX, Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy. Heart 2007 93 488 490. doi: 10.1136/hrt.2006.087387.
91. Elkayam U, Risk of subsequent pregnancy in women with a history of peripartum cardiomyopathy. J Am Coll Cardiol 2014 64 1629 1636. doi: 10.1016/j.jacc.2014.07.961.
92. Fett JD, Shah TP, McNamara DM, Why do some recovered peripartum cardiomyopathy mothers experience heart failure with a subsequent pregnancy? Curr Treat Options Cardiovasc Med 2015 17 354. doi: 10.1007/s11936-014-0354-x.
93. Mouquet F, Lions C, de Groote P, Bouabdallaoui N, Willoteaux S, Dagorn J, Deruelle P, Lamblin N, Bauters C, Beregi JP, Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging. Eur Radiol 2008 18 2765 2769. doi: 10.1007/s00330-008-1067-x.
94. Lampert MB, Weinert L, Hibbard J, Korcarz C, Lindheimer M, Lang RM, Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. Am J Obstet Gynecol 1997 176 pt 1 189 195
95. Ruys TP, Roos-Hesselink JW, Hall R, Subirana-Domènech MT, Grando-Ting J, Estensen M, Crepaz R, Fesslova V, Gurvitz M, De Backer J, Johnson MR, Pieper PG, Heart failure in pregnant women with cardiac disease: data from the ROPAC. Heart 2014 100 231 238. doi: 10.1136/heartjnl-2013-304888.
96. Cénac A, Gaultier Y, Devillechabrolle A, Moulias R, Enterovirus infection in peripartum cardiomyopathy. Lancet 1988 2 968 969
97. Bültmann BD, Klingel K, Näbauer M, Wallwiener D, Kandolf R, High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 2005 193 363 365. doi: 10.1016/j.ajog.2005.01.022.
98. Fett JD, Viral particles in endomyocardial biopsy tissue from peripartum cardiomyopathy patients. Am J Obstet Gynecol 2006 195 330 331; author reply 331. doi: 10.1016/j.ajog.2005.10.810.
99. Arora NP, Mohamad T, Mahajan N, Danrad R, Kottam A, Li T, Afonso LC, Cardiac magnetic resonance imaging in peripartum cardiomyopathy. Am J Med. Sci 2014 347 112 117. doi: 10.1097/MAJ.0b013e31828155e3.
100. Renz DM, Röttgen R, Habedank D, Wagner M, Böttcher J, Pfeil A, Dietz R, Kivelitz D, Elgeti T, New insights into peripartum cardiomyopathy using cardiac magnetic resonance imaging. Rofo 2011 183 834 841. doi: 10.1055/s-0031-1281600.
101. Kara RJ, Bolli P, Karakikes I, Matsunaga I, Tripodi J, Tanweer O, Altman P, Shachter NS, Nakano A, Najfeld V, Chaudhry HW, Fetal cells traffic to injured maternal myocardium and undergo cardiac differentiation. Circ Res 2012 110 82 93. doi: 10.1161/CIRCRESAHA.111.249037.
102. Cénac A, Sacca-Vehounkpe J, Poupon J, Dossou-Yovo-Akindes R, D'Almeida-Massougbodji M, Tchabi Y, Agboton H, Serum selenium and dilated cardiomyopathy in Cotonou, Benin [in French]. Med Trop (Mars) 2009 69 272 274
103. Homans DC, Peripartum cardiomyopathy. N Engl J Med 1985 312 1432 1437. doi: 10.1056/NEJM198505303122206.
104. Bajou K, Herkenne S, Thijssen VL, D'Amico S, Nguyen NQ, Bouché A, Tabruyn S, Srahna M, Carabin JY, Nivelles O, Paques C, Cornelissen I, Lion M, Noel A, Gils A, Vinckier S, Declerck PJ, Griffioen AW, Dewerchin M, Martial JA, Carmeliet P, Struman I, PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin. Nat Med 2014 20 741 747. doi: 10.1038/nm.3552.
105. Patten IS, Rana S, Shahul S, Rowe GC, Jang C, Liu L, Hacker MR, Rhee JS, Mitchell J, Mahmood F, Hess P, Farrell C, Koulisis N, Khankin EV, Burke SD, Tudorache I, Bauersachs J, del Monte F, Hilfiker-Kleiner D, Karumanchi SA, Arany Z, Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 2012 485 333 338. doi: 10.1038/nature11040.
106. Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G, Cooper M, Laznik D, Chinsomboon J, Rangwala SM, Baek KH, Rosenzweig A, Spiegelman BM, HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature 2008 451 1008 1012. doi: 10.1038/nature06613.
107. Powe CE, Levine RJ, Karumanchi SA, Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 2011 123 2856 2869. doi: 10.1161/CIRCULATIONAHA.109.853127.
108. Bdolah Y, Lam C, Rajakumar A, Shivalingappa V, Mutter W, Sachs BP, Lim KH, Bdolah-Abram T, Epstein FH, Karumanchi SA, Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia? Am J Obstet Gynecol 2008 198 428.e1 428.e6. doi: 10.1016/j.ajog.2007.10.783.
109. Damp J, Givertz MM, Semigran M, Alharethi R, Ewald G, Felker GM, Bozkurt B, Boehmer J, Haythe J, Skopicki H, Hanley-Yanez K, Pisarcik J, Halder I, Gorcsan J 3rd, Rana S, Arany Z, Fett JD, McNamara DM, IPAC Investigators Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study. JACC Heart Fail. 2016 Feb 27. pii: S2213-1779(16)00018-4. doi: 10.1016/j.jchf.2016.01.004.
110. Thadhani R, Hagmann H, Schaarschmidt W, Roth B, Cingoez T, Karumanchi SA, Wenger J, Lucchesi KJ, Tamez H, Lindner T, Fridman A, Thome U, Kribs A, Danner M, Hamacher S, Mallmann P, Stepan H, Benzing T, Removal of soluble Fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia. J Am Soc Nephrol 2016 27 903 913. doi: 10.1681/ASN.2015020157.
111. Łasińska-Kowaraa M, Lango R, Kowalik M, Jarmoszewicz K, Accelerated heart function recovery after therapeutic plasma exchange in patient treated with biventricular mechanical circulatory support for severe peripartum cardiomyopathy. Eur J Cardiothorac Surg 2014 46 1035 1036. doi: 10.1093/ejcts/ezu178.
112. Karaye KM, Lindmark K, Henein MY, Left ventricular structure and function among sisters of peripartum cardiomyopathy patients. Int J Cardiol 2015 182 34 35. doi: 10.1016/j.ijcard.2014.12.102.
113. Horne BD, Rasmusson KD, Alharethi R, Budge D, Brunisholz KD, Metz T, Carlquist JF, Connolly JJ, Porter TF, Lappé DL, Muhlestein JB, Silver R, Stehlik J, Park JJ, May HT, Bair TL, Anderson JL, Renlund DG, Kfoury AG, Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum cardiomyopathy. Circ Cardiovasc Genet 2011 4 359 366. doi: 10.1161/CIRCGENETICS.110.959205.
114. Bakre MM, Zhu Y, Yin H, Burton DW, Terkeltaub R, Deftos LJ, Varner JA, Parathyroid hormone-related peptide is a naturally occurring, protein kinase A-dependent angiogenesis inhibitor. Nat Med 2002 8 995 1003. doi: 10.1038/nm753.
115. Ntusi NB, Wonkam A, Shaboodien G, Badri M, Mayosi BM, Frequency and clinical genetics of familial dilated cardiomyopathy in Cape Town: implications for the evaluation of patients with unexplained cardiomyopathy. S Afr Med J 2011 101 394 398
116. Massad LS, Reiss CK, Mutch DG, Haskel EJ, Familial peripartum cardiomyopathy after molar pregnancy. Obstet Gynecol 1993 81 pt 2 886 888
117. Pearl W, Familial occurrence of peripartum cardiomyopathy. Am Heart J 1995 129 421 422
118. Pierce JA, Price BO, Joyce JW, Familial occurrence of postpartal heart failure. Arch Intern Med 1963 111 651 655
119. van Spaendonck-Zwarts KY, Posafalvi A, van den Berg MP, Hilfiker-Kleiner D, Bollen IA, Sliwa K, Alders M, Almomani R, van Langen IM, van der Meer P, Sinke RJ, van der Velden J, Van Veldhuisen DJ, van Tintelen JP, Jongbloed JD, Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. Eur Heart J 2014 35 2165 2173. doi: 10.1093/eurheartj/ehu050.
120. Morales A, Painter T, Li R, Siegfried JD, Li D, Norton N, Hershberger RE, Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation 2010 121 2176 2182. doi: 10.1161/CIRCULATIONAHA.109.931220.
121. Ware JS, Li J, Mazaika E, Yasso CM, DeSouza T, Cappola TP, Tsai EJ, Hilfiker-Kleiner D, Kamiya CA, Mazzarotto F, Cook SA, Halder I, Prasad SK, Pisarcik J, Hanley-Yanez K, Alharethi R, Damp J, Hsich E, Elkayam U, Sheppard R, Kealey A, Alexis J, Ramani G, Safirstein J, Boehmer J, Pauly DF, Wittstein IS, Thohan V, Zucker MJ, Liu P, Gorcsan J 3rd, McNamara DM, Seidman CE, Seidman JG, Arany Z, IMAC-2 and IPAC Investigators Shared genetic predisposition in peripartum and dilated cardiomyopathies. N Engl J Med 2016 374 233 241. doi: 10.1056/NEJMoa1505517.
122. Roberts AM, Ware JS, Herman DS, Schafer S, Baksi J, Bick AG, Buchan RJ, Walsh R, John S, Wilkinson S, Mazzarotto F, Felkin LE, Gong S, MacArthur JA, Cunningham F, Flannick J, Gabriel SB, Altshuler DM, Macdonald PS, Heinig M, Keogh AM, Hayward CS, Banner NR, Pennell DJ, O'Regan DP, San TR, de Marvao A, Dawes TJ, Gulati A, Birks EJ, Yacoub MH, Radke M, Gotthardt M, Wilson JG, O'Donnell CJ, Prasad SK, Barton PJ, Fatkin D, Hubner N, Seidman JG, Seidman CE, Cook SA, Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Sci Transl Med 2015 7 270ra6. doi: 10.1126/scitranslmed.3010134.
123. Herman DS, Lam L, Taylor MR, Wang L, Teekakirikul P, Christodoulou D, Conner L, DePalma SR, McDonough B, Sparks E, Teodorescu DL, Cirino AL, Banner NR, Pennell DJ, Graw S, Merlo M, Di Lenarda A, Sinagra G, Bos JM, Ackerman MJ, Mitchell RN, Murry CE, Lakdawala NK, Ho CY, Barton PJ, Cook SA, Mestroni L, Seidman JG, Seidman CE, Truncations of titin causing dilated cardiomyopathy. N Engl J Med 2012 366 619 628. doi: 10.1056/NEJMoa1110186.
124. Sliwa K, Hilfiker-Kleiner D, Mebazaa A, Petrie MC, Maggioni AP, Regitz-Zagrosek V, Schaufelberger M, Tavazzi L, van Veldhuisen DJ, Roos-Hesslink JW, Shah AJ, Seferovic PM, Elkayam U, van Spaendonck-Zwarts K, Bachelier-Walenta K, Mouquet F, Kraigher-Krainer E, Hall R, Ponikowski P, McMurray JJ, Pieske B, EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM. Eur J Heart Fail 2014 16 583 591. doi: 10.1002/ejhf.68.
125. National Institutes of Health. NIH RePORTer. https://projectreporter.nih.gov/reporter.cfm. Accessed October 15, 2015